<DOC>
	<DOCNO>NCT00332410</DOCNO>
	<brief_summary>The purpose study determine whether patient compromise renal function ( CrCl &lt; 50mL/min ) receive intravenous voriconazole experience adverse effect relate serum chemistry image study kidney due potential accumulation vehicle cyclodextran .</brief_summary>
	<brief_title>Intravenous Voriconazole Patients With Renal Compromise</brief_title>
	<detailed_description>The purpose study determine whether patient compromise renal function ( CrCl &lt; 50mL/min ) receive intravenous voriconazole experience adverse effect relate serum chemistry image study kidney due potential accumulation vehicle cyclodextran . previously show large multi-centered , prospective , randomize study voriconazole superior gold standard amphotericin B treatment patient invasive aspergillosis - disease significant morbidity mortality . In patient infection severe renal insufficiency may deny best therapy due accumulation diluent unknown clinical consequence . Qualifying quantify consequence important patient potentially life-threatening therapy unduly deny .</detailed_description>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Patients &gt; 18 year old receiving voriconazole serum creatinine &gt; 2mg/dl ( proxy marker Creatinine clearance &lt; 50ml/min ) . Control group study serum creatinine &lt; 1.5mg/dl . Solid organ transplant patient . Patient receive least 2 dos voriconazole .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Voriconazole</keyword>
	<keyword>renal transplant</keyword>
	<keyword>kidney function</keyword>
	<keyword>kidney</keyword>
</DOC>